| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 52.172 | 191.801 | 205.312 | 223.471 | 252.868 | 315.499 |
| Total Income - EUR | - | - | - | - | 52.175 | 191.835 | 205.315 | 223.479 | 252.877 | 315.602 |
| Total Expenses - EUR | - | - | - | - | 48.328 | 160.440 | 170.281 | 196.186 | 220.451 | 279.561 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.846 | 31.395 | 35.034 | 27.293 | 32.426 | 36.042 |
| Net Profit/Loss - EUR | - | - | - | - | 3.324 | 29.840 | 33.219 | 25.371 | 30.245 | 29.966 |
| Employees | - | - | - | - | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Lena Farmaceutica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 17 | 0 | 0 | 0 | 1.819 | 3.739 |
| Current Assets | - | - | - | - | 26.830 | 55.320 | 75.903 | 88.146 | 92.274 | 121.797 |
| Inventories | - | - | - | - | 11.121 | 23.830 | 31.836 | 36.168 | 43.921 | 57.359 |
| Receivables | - | - | - | - | 13.306 | 24.929 | 25.932 | 30.868 | 41.004 | 49.897 |
| Cash | - | - | - | - | 2.403 | 6.561 | 18.136 | 21.110 | 7.349 | 14.541 |
| Shareholders Funds | - | - | - | - | 3.366 | 33.142 | 65.626 | 74.039 | 94.171 | 111.702 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 23.670 | 22.220 | 10.278 | 14.155 | 918 | 14.794 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Lena Farmaceutica S.r.l.